Several other equities research analysts have also commented on the company. ValuEngine lowered Zymeworks from a buy rating to a hold rating in a research note on Saturday, May 18th. Zacks Investment Research lowered Zai Lab from a buy rating to a hold rating in a research note on Saturday, June 15th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $11.50.
NASDAQ:VRA opened at $11.38 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 4.15 and a quick ratio of 2.53. The stock has a market cap of $389.36 million, a price-to-earnings ratio of 19.29 and a beta of 0.86. Vera Bradley has a one year low of $7.94 and a one year high of $17.38. The business has a fifty day moving average of $11.47.
In other Vera Bradley news, major shareholder Bradley Baekgaard Fami Barbara sold 16,412 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $11.36, for a total value of $186,440.32. Following the completion of the sale, the insider now owns 139,740 shares in the company, valued at approximately $1,587,446.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Joan B. Hall sold 70,000 shares of the stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $11.53, for a total value of $807,100.00. The disclosure for this sale can be found here. Insiders sold a total of 374,702 shares of company stock valued at $4,364,154 over the last 90 days. 27.30% of the stock is currently owned by company insiders.
A number of hedge funds have recently modified their holdings of the business. Quantamental Technologies LLC purchased a new position in shares of Vera Bradley during the first quarter valued at about $32,000. BNP Paribas Arbitrage SA grew its position in shares of Vera Bradley by 67.2% during the first quarter. BNP Paribas Arbitrage SA now owns 4,744 shares of the textile maker’s stock valued at $63,000 after purchasing an additional 1,907 shares in the last quarter. Metropolitan Life Insurance Co NY purchased a new position in shares of Vera Bradley during the first quarter valued at about $100,000. MetLife Investment Advisors LLC purchased a new position in shares of Vera Bradley during the first quarter valued at about $139,000. Finally, Oppenheimer Asset Management Inc. grew its position in shares of Vera Bradley by 9.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 10,552 shares of the textile maker’s stock valued at $140,000 after purchasing an additional 892 shares in the last quarter. Institutional investors and hedge funds own 66.98% of the company’s stock.
About Vera Bradley
Vera Bradley, Inc, together with its subsidiaries, designs, manufactures, and sells women's handbags, luggage and travel items, fashion and home accessories, and gifts. It operates through two segments, Direct and Indirect. The company offers totes, crossbodies, satchels, clutches, backpacks, baby bags, and lunch bags; accessories, including wallets, wristlets, eyeglass cases, scarves, and various technology accessories; and travel products, such as rolling luggage, cosmetics, and travel and packing accessories, as well as travel bags comprising duffel and weekend bags.
Featured Story: Net Income
Receive News & Ratings for Vera Bradley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vera Bradley and related companies with MarketBeat.com's FREE daily email newsletter.